Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PreciGenome is a private life science tools and microfluidics company based in San Jose, California. The company develops and sells commercial instruments, consumables, reagents, and OEM solutions for lipid nanoparticle synthesis, PCR and digital PCR workflows, microfluidic flow control, droplet generation, single-cell applications, and related diagnostics uses. Its NanoGenerator product line is positioned as a scalable platform for formulation of lipid nanoparticles, liposomes, and PLGA nanoparticles from research scale through GMP-oriented manufacturing workflows. PreciGenome appears to operate primarily as a tools and platform provider rather than a therapeutic drug developer, serving researchers and developers working in genomic medicine, delivery, and assay development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PreciGenome.